Back to search
Frail Elderly
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Frail Elderly trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Frail Elderly trials you may qualify forBackground: \- Biomarkers are substances in people s blood and tissues. They help researchers understand diseases and signs of aging. Scientists want to do mor…
This is a prospective, single-center, open-label, single-arm clinical study designed to evaluate the efficacy and safety of Pola-ZR-Glo (Polatuzumab Vedotin, Za…
The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience…
To learn if adding epcoritamab to the treatment combination R-miniCVP (rituximab, cyclophosphamide, vincristine, prednisone) can help to control newly diagnosed…
The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients…
The assessment and systematic integration of physical activity into the care pathway of frail elderly people is essential to prevent loss of independence and im…
The goal of this clinical trial is to implement a personalized training program to prevent functional decline in frail subjects but not yet disable. The purpose…
This prospective observational study aims to describe changes in physical function and fall risk in adults aged 70 years and older participating in a routine mu…